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Background/aim: In this study, we aimed to assess the cancer risk among patients with periodontal disease.
Materials and methods: Patients diagnosed with periodontal diseases at Hacettepe University between 2007 and 2012 were included
and data on the diagnosis of any cancer after periodontal disease were collected from patient files. The age- and sex-standardized
incidence rates (SIRs) were calculated using Turkish National Cancer Registry 2013 data.
Results: A total of 5199 patients were included. Median follow-up was 7.2 years. Patients with periodontal diseases had 17% increased
risk of cancer compared with the expected counts for the corresponding age and sex groups (SIR: 1.17; 95% CI: 1.04–1.3, P = 0.006). The
increased cancer risk was statistically significant in women (SIR: 1.24; 95% CI: 1.05–1.45, P = 0.008) but not in men. Among women
with periodontal disease, the risks of breast cancer (SIR: 2.19) and head and neck cancer (SIR: 4.71) were significantly increased. Among
men, the risks of prostate cancer (SIR: 1.84), head and neck cancer (SIR: 3.55), and hematological cancers (SIR: 1.76) were significantly
increased.
Conclusion: This study showed that periodontal diseases were associated with increased risk of several cancers. Besides other wellknown benefits for health, the provision of oral/dental health should be considered and employed as a cancer prevention measure.
Key words: Breast cancer, cancer risk, periodontal disease, prostate cancer

1. Introduction
Periodontal diseases are polymicrobial chronic
inflammatory diseases that cause the damage of the
periodontal ligaments and collapse of the adjacent alveolar
bone. Periodontal diseases have many stages ranging from
mild and short-lived gingivitis to severe periodontitis,
which develops after persistent inflammation [1]. The
worldwide prevalence of periodontal disease can be
up to 90% and gingivitis affects almost half of the adult
population [2].
It is thought that periodontal diseases may cause local
inflammation as well as important systemic diseases in
distant organs including cancers. Proposed mechanisms
for this association include the bacteremia secondary to the
weakened periodontal epithelium and systemic immune
dysregulation [3,4]. The dysbiotic microenvironment in
periodontal diseases is stated to create both an immune-

evasive and a proinflammatory state, which is required for
its persistence [3]. The role of systemic inflammation in
increased cancer risk was supported by multiple human
studies by the demonstration of increased circulatory
cytokines and chemokines in periodontal diseases [5,6].
Several epidemiologic studies have shown that
periodontal diseases are associated with an increased
risk of cancers including, but not limited to, breast, lung,
prostate, and hematological cancers [7–10]. However,
assessment methods for periodontal disease in large
epidemiological studies were heterogeneous as most
studies utilized self-reported data [11] or administrative
data [12] rather than examination by a periodontist. We
previously showed that moderate to severe periodontitis
diagnosed by a periodontist was associated with a 77%
increase in cancer risk [13]. This high risk prompted us
to further investigate cancer risk in a larger population of
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patients with any periodontal disease, including milder
forms of periodontitis, gingivitis, etc. We performed this
study to examine cancer risk in a large cohort of over 5000
patients with periodontal disease in comparison with the
data of the Turkish National Cancer Registry (TNCR) in
the same age and sex groups [14].
2. Materials and methods
2.1. Patients
This study was performed in the Hacettepe University
Dentistry and Oncology Hospitals in Ankara, Turkey.
Patients diagnosed with any periodontal disease in the
Hacettepe University Oral Diagnosis Department and
referred to the Periodontology Department between 2007
and 2012 were identified from the hospital registry. Data
on the diagnosis of any cancer after periodontal disease
were collected from patient files and oncology registries
where available. Patients younger than 50 years of age and
those with a prior cancer diagnosis were excluded. TNCR
2013 data were used for comparison of age- and sexspecific incidence rates.
The patients were diagnosed using standard clinical
and radiographic parameters in accordance with the
Periodontal Disease Classification System of the American
Academy of Periodontology [15].
The study was approved by the Ethics Committee of
Hacettepe University on 24.08.2017 with approval number
17/708.
2.2. Statistical analysis
Standardized incidence rates were calculated after
adjustment for age and sex and compared with age and
sex-specific incidence rates (SIRs) abstracted from the
2013 TNCR data [14]. The observed number of cases is
based on the number of individuals diagnosed with cancer
upon follow-up after the diagnosis of periodontal disease.
Expected cases represent the total number of patients that
would have been reported to the cancer registry within the
same period of follow-up as per the TNCR rates under the
null hypothesis of no increased risk, given the age and sex
structure. The SIR and the 95% confidence interval (CI)
for the SIR were calculated using OpenEpi version 3.01
software. A ratio greater than 1.00 indicates that there
were more cases observed than expected. P < 0.05 was
considered statistically significant.
3. Results
A total of 5199 patients with periodontal disease were
included in the study. The median age was 57.7 years
and 59% of the patients were female. Median follow-up
was calculated as 7.2 years. Three hundred and nineteen
new cancer cases were observed in follow-up. The most
common cancers were breast cancer (67 of 153 cases) in
women and prostate cancer (40 of 166 cases) in men.

The SIRs with 95% CIs are shown in Table 1. Patients
with periodontal disease had 17% increased cancer risk
(SIR: 1.17, 95% CI: 1.04–1.30, P = 0.006) compared to
TNCR data for similar age and sex groups. The overall
increased cancer risk did not reach statistical significance
in men (SIR: 1.11, 95% CI: 0.95–1.28, P = 0.20), while in
women with periodontal disease increased cancer risk was
statistically significant (SIR: 1.24, 95% CI: 1.05–1.45, P =
0.008).
In women with periodontal disease, breast cancer (SIR:
2.19, 95% CI: 1.71–2.77, P < 0.001) and head and neck
cancer risks (SIR: 4.71, 95% CI: 2.19–8.93, P < 0.001) were
significantly increased. In males, prostate cancer (SIR:
1.84, 95% CI: 1.34–2.49, P < 0.001), head and neck cancer
(SIR: 3.55, 95% CI 1.87–6.17, P < 0.001), and hematological
cancer risks (SIR: 1.76, 95% CI: 0.97–2.93, P = 0.039) were
found to be higher than the general population data of
similar age and sex groups (Table 1).
4. Discussion
In this study, we showed that the presence of any
periodontal disease increased the risk of cancer by 17%
in patients from a comprehensive dentistry hospital. The
association was particularly significant for breast and head
and neck cancer in women and prostate, head and neck,
and hematological cancers in men. These findings are in
accordance with the findings obtained in our previous
study [13] and showed that in a population of patients
with milder forms of periodontal disease, cancer risk is
still increased, but the magnitude of the risk is lower than
the risk for those with moderate to severe periodontitis
(Table 2).
A number of underlying mechanisms were proposed
for the association between periodontal disease and
cancer. These include systemic inflammation induced
by the periodontal disease, immune dysregulation, and
alteration of the oral flora [16–18]. Periodontitis was
proposed to be associated with subclinical systemic
inflammation [3,19]. Similar associations have been
known for various chronic inflammatory disorders such
as inflammatory bowel disease and colorectal cancer [3].
The increase in systemic markers of inflammation such
as C-reactive protein, interleukin 6, and tumor necrosis
factor-α in the plasma of periodontitis patients supports
this association [5,6]. Increased levels of myeloperoxidase
and superoxide dismutase, which are among the main
regulators of inflammation, were found in periodontitis
[20]. An increased gastric cancer risk due to increased
inflammation in periodontitis was also proposed [21].
These findings led to the notion that immediate treatment
of periodontal disease may reduce the inflammation
and its remote effects on other organs [19]. Although
mechanisms are unclear, periodontal disease treatment
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Table 1. Standardized incidence ratios (SIRs) with 95% confidence intervals
for all
and specific cancers in patients with periodontal disease.
All

5199 319

273.8

1.17 1.04–1.30

0.006

Male total

2151 166

150.2

1.11 0.95–1.28

0.197

Male prostate

40

21.7

1.84 1.34–2.49

<0.001

Male lung

23

38.3

0.6

0.013

Male head and neck

11

3.1

3.55 1.87–6.17

<0.001

Male hematologic

13

7.4

1.76 0.97–2.93

0.039

Male colorectal

14

14.2

0.99 0.56–1.62

0.957

Male bladder

13

12.3

1.06 0.59–1.77

0.842

Male stomach

7

9.2

0.76 0.33–1.50

0.468

4

2

2

0.64–4.82

0.157

123.6

1.24 1.05–1.45

0.008

Male pancreas
Female total

3048 153

0.39–0.89

Female breast

67

30.6

2.19 1.71–2.77

<0.001

Female lung

9

7.9

1.14 0.56–2.10

0.695

Female head and neck

8

1.7

4.71 2.19–8.93

<0.001

Female hematologic

8

7.4

1.08 0.5–2.05

0.825

Female colorectal

8

11.2

0.71 0.33–1.36

0.339

Female bladder

3

2.1

1.43 0.36–3.90

0.535

Female stomach

1

4

0.25 0.01–1.23

0.134

Female pancreas

3

2.8

1.07 0.27–2.92

0.905

Table 2. Comparison of standardized incidence ratios (SIR) with 95% confidence intervals for all and specific cancers in our two
studies.
Patient population
Any periodontal disease (current study) SIR (95% CI) Moderate-severe periodontitis [13] SIR (95% CI)
All

1.17 (1.04–1.3)

1.77 (1.17–2.58)

Male total

1.11 (0.95–1.28)

1.69 (0.92–2.89)

Male prostate

1.84 (1.34–2.49)

3.75 (0.95–10.21)

Male hematological

1.76 (0.97–2.93)

6.97 (1.77–18.98)

Female total

1.24 (1.05–1.45)

1.84 (1.02–3.07)

Female breast

2.19 (1.71–2.77)

2.40 (0.88–5.33)

N

5199

280

reduced the subsequent cancer risk by 28% in one study
[22], which may be partly explained by a reduction in
inflammation.
The highly vascular and fragile structure of the gingival
tissue makes it a vulnerable entry site for oral pathogens
during daily activities like eating and tooth brushing [6].
Carcinogenic byproducts of oral bacteria metabolism are
suggested to be important in the link between periodontal
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disease and cancer [19]. For example, increased salivary
acetaldehyde levels in poor dental health have been
shown [23] and may be related to the mediation of oral
microbiome contributions to cancer risk in periodontal
disease. Oral microbiome changes have been reported in
oral cavity cancers [24] and may be related to increased
head and neck cancer risk in periodontitis patients.
Periodontal pathogens also seem to play roles in the
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carcinogenesis of distant organs. Increased levels of
Fusobacterium nucleatum and Porphyromonas gingivalis
in the tumor tissue and feces of colorectal cancer patients
and increased levels of Porphyromonas gingivalis in tumor
tissue of esophagus cancer patients have been shown [25–
27], but routes of dissemination and pathogenetic roles are
yet to be determined.
Numerous wide-scale epidemiological studies reported
the association between periodontal disease and cancer
risk. Periodontal diseases were found to be associated
with a 14% increased cancer risk in the WHI cohort [10].
A cohort study from Taiwan that included more than
40,000 patients with chronic periodontitis showed a 23%
increase in total cancer risk compared with age-matched
controls in 5-year follow-up. A lower 5-year cancer-free
survival in the chronic periodontitis cohort was also an
interesting finding indicating a prognostic role of chronic
periodontitis in cancer [28]. In a study by Michaud et al.,
a 13% increased risk of total cancer was observed among
males who never smoked with periodontal disease. In this
study, only smoking-related cancers appeared to increase.
This finding suggested that alterations of immune
pathways may play an important role in the mediation
of periodontal disease and cancer association, giving the
effects of smoking on altered immune response [8].
Breast cancer risk was increased more than twofold in
patients with periodontal disease in this study, similar to
our previous study but somewhat higher than in previous
studies in the literature. In a study by Freudenhelm et
al., in the WHI cohort, 73,737 women were followed for
6.7 years and the presence of periodontal disease was
associated with 14% increased breast cancer risk [11].
Similarly, in a study from Taiwan, chronic periodontitis
was associated with 23% increased breast cancer risk
[28]. In the NHANES I follow-up study, the presence of
periodontitis was associated with a 32% increased risk of
breast cancer but gingivitis did not show an increased risk
[29]. In a study by Söber et al., the presence of any missing
molars in the mandible was associated with increased
breast cancer risk (odds ratio (OR) of 2.36) [30]. The latter
two studies also showed higher risks of cancer in patients
with more advanced periodontal disease resulting in
tooth loss. Our lack of radiological data precluded such a
stratification in our study.
There are conflicting data in the literature on the link
between prostate cancer and periodontal disease. Michaud
et al. reported an inverse association between tooth loss
and prostate cancer in a male health professionals cohort
but did not include nonaggressive prostate cancer in the
analyses [9]. Hujoel and Lee reported increased prostate
cancer risks with periodontitis but with rather different
magnitudes (81% vs. 14%) [7,29]. Prostate cancer risk
was increased by 84% in our study and this finding may
be partly explained by our inclusion of all prostate cancer

cases in the analyses. Differences in the gut microbiome of
prostate cancer patients and patients with benign prostatic
conditions were reported [31]. Estemalik et al. showed
oral pathogens in patients with chronic prostatitis and
benign prostatic hyperplasia [32]. These findings indicate
a possible association between the oral microbiome and
prostate diseases, but comments on driver or bystander
effects could not be made without further data [33].
Periodontal diseases are consistently associated with an
increased risk of head and neck cancers, not surprisingly
when considering the role of microbiome changes and
chronic inflammation in both conditions [19]. Like
periodontal diseases, tooth loss alone was also associated
with head and neck cancer risk [34]. In a metaanalysis of
studies published before March 2013, periodontal disease
was associated with an OR of 2.63 for head and neck
cancers. Although smoking and alcohol are among the
most common risk factors for both periodontal disease
and head and neck cancer, in the studies covaried for
smoking and alcohol, periodontal disease still remained
an independent risk factor with an OR of 2.23 [35]. Our
findings are consistent with the previous literature and
showed a 3- to 4-fold increased cancer risk in both males
and females in a heterogeneous population of patients
with various periodontal diseases.
There are limited data on the literature regarding
the link between hematological cancers and periodontal
disease. Michaud et al. reported a 30% increase in
hematological cancer risk in periodontal disease in a study
of male health professionals [9]. In the Health Professionals
Follow-Up Study, periodontal disease was associated
with increased non-Hodgkin lymphoma and chronic
lymphocytic leukemia/small lymphocytic lymphoma
risks [36]. Hiraki et al. reported no significant association
with periodontal disease and hematological cancers [37].
Hematological cancers were increased in males in both of
our studies, but due to the low number of cases, SIR values
for hematological cancer subtypes were not calculated.
The link between lung cancer and periodontal disease
was investigated several times in the literature [9,37–39].
After adjustment for smoking, some studies did not
find an independent association between periodontal
diseases and lung cancer [29,38], which may be due to
overadjustment in regard to healthy behavior patterns.
There was an inverse association between periodontal
disease and lung cancer in men, which was an unexpected
finding. Due to lack of adjustment for smoking in our
study, we think that underreporting may be the main
reason for the less frequent occurrence of lung cancer in
men with periodontal disease.
Strengths of our study include the relatively large
sample size and diagnosis of periodontal disease by an
experienced team. Confirmation of cancer diagnoses from
the pathology reports rather than administrative data was
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important for the reliability of results. However, our study
is subject to a number of limitations. First of all, cancer
data were taken from patients’ files and hospital records;
thus, cancers diagnosed in other centers may have been
underreported, altering the results biased towards the
null. In addition, the severity and generality of periodontal
disease were not evaluated. This prevented us from
making further comments on the association of specific
periodontal disease parameters and cancer risk. Another
limitation was the inability to perform adjustments for
factors such as smoking, socioeconomic status, diet, and
comorbidities due to lack of data for most patients. The
absence of family histories may also be considered among
limitations due to possible shared susceptibility driving
both conditions, although this shared risk is most evident
in the aggressive periodontitis that occurs in early ages
[40]. Our study only included patients older than 50 years,

which lessens the possibility of confounding due to genetic
susceptibility.
Routine clinical applications regarding periodontal
disease and cancer risk have yet to be defined. Periodontal
disease per se might have a role in carcinogenesis or it
might simply be a consequence of an unhealthy lifestyle
and habits [41]. Prospective studies with long-term followup may aid in discrimination in the future.
In conclusion, these data suggest that chronic
inflammatory periodontal diseases are not only a health
problem that affects the oral cavity but also has the potential
to increase the risk of cancer in local and remote organs by
microbiological and immunological mechanisms. Besides
other well-known health benefits, maintaining oral/dental
health should also be considered and employed as a cancer
prevention measure.
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